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Cl− is a major anion in mammalian cells involved in transport pro-
cesses that determines the intracellular activity of many ions and
plasmamembrane potential. Surprisingly, a role of intracellular Cl−
(Cl−in) as a signaling ion has not been previously evaluated. Here
we report that Cl−in functions as a regulator of cellular Na
+ and
HCO3
− concentrations and transepithelial transport through mod-
ulating the activity of several electrogenic Na+-HCO3
− transport-
ers. We describe the molecular mechanism(s) of this regulation by
physiological Cl−in concentrations highlighting the role of GXXXP
motifs in Cl− sensing. Regulation of the ubiquitous Na+-HCO3− co-
transport (NBC)e1-B is mediated by two GXXXP-containing sites;
regulation of NBCe2-C is dependent on a single GXXXP motif; and
regulation of NBCe1-A depends on a cryptic GXXXP motif. In the
basal state NBCe1-B is inhibited by high Cl−in interacting at a low
affinity GXXXP-containing site. IP3 receptor binding protein re-
leased with IP3 (IRBIT) activation of NBCe1-B unmasks a second
high affinity Cl−in interacting GXXXP-dependent site. By contrast,
NBCe2-C, which does not interact with IRBIT, has a single high
affinity N-terminal GXXP-containing Cl−in interacting site. NBCe1-
A is unaffected by Cl−in between 5 and 140 mM. However, dele-
tion of NBCe1-A residues 29–41 unmasks a cryptic GXXXP-contain-
ing site homologous with the NBCe1-B low affinity site that is
involved in inhibition of NBCe1-A by Cl−in. These findings reveal
a cellular Cl−in sensing mechanism that plays an important role in
the regulation of Na+ and HCO3
− transport, with critical implica-
tions for the role of Cl− in cellular ion homeostasis and epithelial
fluid and electrolyte secretion.
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Cl
− and HCO3
− are the two major intracellular anions in
mammalian cells. Specific transporters, channels, and the
membrane potential tightly regulate their extracellular and in-
tracellular concentrations. In turn, Cl− and HCO3
− regulate the
concentration of other ions, including Na+, K+, and SO4
2−, ei-
ther directly or indirectly. Known ubiquitous Cl−- and HCO3
−-
coupled transporters include the NaCl cotransporters NCCs,
the KCl cotransporters KCCs, the Na+/K+/2Cl− cotransporter
NKCC1 (1), the SLC26 Cl−/HCO3
− exchangers and channels
(2, 3), and members of the SLC4 exchangers and cotransporters
family (4). The intracellular Cl− (Cl−in) concentration is also
regulated by the ClCs (5) and Anoctamines Cl− channels (6). Cl−
plays a role in a wide variety of cellular transport functions, in-
cluding regulation of the membrane potential (6), cell volume
(2), systemic and cellular acid–base balance (4), and trans-
epithelial fluid and electrolyte secretion (7). In addition, Cl− was
reported to regulate transient receptor potential (TRP) channels
(8), receptors assembly and function (9–11), activation of Neutro-
phil β2 Integrins (12), and the cell cycle (13).
Like Cl−, HCO3
− also has many important physiological roles,
being the principal biological pH buffer (7) and an activator of
the soluble adenylyl cyclase (14). In epithelia, HCO3
− has a key role
in tissue/cell viability. Among other fundamental roles, HCO3
−
drives Cl− absorption and fluid secretion, stimulates mucin
secretion, and controls solubilization of secreted macro-
molecules (7). Epithelial HCO3
− secretion is fueled by the cel-
lular Na+ gradient, which provides the driving force for HCO3
−
entry across the basolateral membrane mediated by the Na+-HCO3
−
cotransport NBCe1-B. HCO3
− then exits the luminal membrane
by the coordinated and coupled functions of the Cl− channel
cystic fibrosis transmembrane conductance regulator (CFTR)
and the electrogenic Cl−/HCO3
− exchanger slc26a6 (3, 7, 15). In
the kidney, NBCe1-A mediates basolateral HCO3
− extrusion
(16, 17). In secretory ducts the basolateral NBCe1-B–mediated
HCO3
− influx is coupled to apical HCO3
− secretion and Cl−
absorption via CFTR and slc26a6 (7). Cl−in is reduced along
the ducts as luminal Cl− is reduced and luminal HCO3
− is
increased (18, 19).
Members of the SLC4 superfamily of HCO3
− cotransporters
are key transporters involved in cellular HCO3
− and Cl− ho-
meostasis (4, 7). The family consists of several subfamilies, in-
cluding the electrogenic NBCe1 and NBCe2, electroneutral
NBCn1 and NBCn2, Cl−-coupled anion exchangers AEs, and the
Na+-dependent Cl−/HCO3
− exchanger NDCBE (4). In a wide
variety of tissues, NBCe1-B mediates the electrogenic transport
of 1Na+ and 2HCO3
− ions (likely Na+-CO3
2−) (4, 17) and
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functions as the main epithelial HCO3
− entry mechanism in the
basolateral membrane of polarized cells (7). Cell-specific elec-
trogenic NBC transporters include NBCe1-A, which is expressed
in the basolateral membrane of the renal proximal tubule (4, 17),
and NBCe2-C, which is found in the choroid plexus (20). IRBIT,
which regulates NBCe1-B (21–23) and NBCn1-A (24), binds to
the IP3 binding domain of the IP3 receptors (IP3Rs) (25). IRBIT
is released from the IP3Rs upon an increase in cellular IP3 (26),
becoming available for regulation of NBCe1-B (21–23), NBCn1-A
(24), CFTR (22, 23), and slc26a6 (27), thereby coordinating the
activation of these transporters and epithelial fluid and HCO3
−
secretion (27).
Cl−in has not been previously considered as a signaling ion.
Rather, Cl− has heretofore mainly been viewed as an ion that is
transported by various channels, coupled to Na+, K+, or HCO3
−
transport, and that plays a role regulating the plasma membrane
potential (1, 7). Importantly, several studies have provided clues
that Cl−in may have regulatory and perhaps signaling functions.
High Cl−in was reported to inhibit the activity of the epithelial
Na+ channel ENaC (28), the permeability of CFTR to HCO3
−
(29), TRPM7 activity (8), and perhaps the activity of the Na+/H+
exchanger NHE1 (30). Muscarinic stimulation of salivary gland
acinar cells resulted in reduction in Cl−in that is required for
Na+ influx by the Na+/H+ exchanger and the Na+/K+/2Cl−
cotransporter (31).
In the present study we asked whether Cl−in functions as
a signaling ion that modulates cellular Na+ and HCO3
− con-
centrations through regulation of electrogenic NBC transporters.
Fig. 1. Effect of Cl−in on the activity of NBCe1-B and NBCe1-A. (A) Example traces of current measured in HeLa cells expressing NBCe1-B and IRBIT and in
pipette solutions containing 5 or 40 mM Cl−; (B) I/V plots at the times indicated by the black circles in each trace. All I/V plots show the raw current under each
condition. (C) Example traces of current recorded in HeLa cells expressing NBCe1-A with pipette solution containing 5 or 140 mM Cl−. (D and E) Cl−in-
dependence of the current density in pA/pF (D) and normalization to the current measured at 5 mM Cl−in at each of the conditions (E) in cells expressing
NBCe1-B alone (blue), NBCe1-B+IRBIT (red), or NBCe1-A (green). The numbers next to the traces indicate the number of experiments. Results are given as
mean ± SEM. In E: *P < 0.01 or better relative to NBCe1-B activity at 5 mM Cl−in;
#P < 0.05 relative to NBCe1-B in the absence of IRBIT with pipette solution
containing 140 mM Cl−in.
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Our data indicate that Cl−in regulates the function of NBCe1-B,
NBCe2-C, and NBCe1-A via a cryptic Cl− sites. In the basal state
NBCe1-B is inhibited by Cl−in interacting with a low affinity Cl
−
site, whereas NBCe1-A is resistant to Cl−in. By contrast, IRBIT-
activated NBCe1-B is inhibited by low and high concentrations
of Cl−in due to interaction with high and low affinity Cl
−
in motifs
that depend on GXXXP motifs. Mutation of the G and P or of
His in GXHXP in the autoinhibitory domain of NBCe1-B
eliminated inhibition by low Cl−in, whereas sparing inhibition of
NBCe1-B by high Cl−in. Mutation of a second GXXXP motif was
required to eliminate inhibition by low affinity Cl−in site. NBCe2-
C is inhibited by a single high affinity GXXXP motif-dependent
Cl−in interacting site. Remarkably, deletion of the first 48 resi-
dues of NBCe1-A or of residues 29–41 uncovered inhibition of
NBCe1-A by Cl−in that was mediated by a GXXXP motif-
dependent site homologous with the second GXXXP motif of
NBCe1-B. These findings reveal a Cl−in sensing mechanism that
modulates the activity of NBCe1-B, NBCe2-C, and NBCe1-A. In
transporting epithelia, such as the pancreatic and salivary ducts
and the choroid plexus, we predict that a reduction in Cl−in will
dramatically increase transepithelial HCO3
− transport and fluid
secretion.
Results
Cl−in Inhibits NBCe1-B but Not NBCe1-A. The activity of the elec-
trogenic NBCe1-A, NBCe1-B, and NBCe2-C were monitored by
measuring the Na+-dependent HCO3
− current. In previous
studies we showed that NBCe1-A and NBCe1-B currents can be
accurately measured by expressing the transporters in HeLa cells
and measuring whole-cell currents (24). The modulation of Cl−in
was achieved by varying the Cl− concentration in the pipette
solution. Fig. 1A shows example current traces, and Fig. 1B
shows the current/voltage (I/V) relationships measured in cells
expressing NBCe1-B in the presence of IRBIT, and in the
presence of 5 or 40 mM Cl−in. The I/Vs show the raw current
under each conditions. To calculate the HCO3
−-activated cur-
rent density, the leak current measured in Hepes-buffered me-
dium before addition of HCO3
− was subtracted from the total
current in the presence of HCO3
− and normalized to the cell
capacitance. Current densities are shown in Fig. 1D, and Fig. 1E
shows the current normalized to that measured at 5 mM Cl− in
under each condition. When NBCe1-B was expressed alone,
raising Cl−in between 5 and 40 mM only modestly inhibited
transport activity by approximately 20%, whereas raising Cl−in
to a nonphysiological concentration of 140 mM inhibited
NBCe1-B activity by approximately 60%, with an EC50 of
approximately 56 ± 4 mM. On the other hand, when NBCe1-B
was activated by IRBIT to prevent autoinhibition (21–23), raising
Cl−in from 5 to 20 mM strongly inhibited NBCe1-B activity by
approximately 65%, with an apparent Ki of 10.2 ± 0.3 mM.
Further increasing Cl−in to 140 mM inhibited the activity by an
additional 15%. The inhibition by Cl−in did not seem to change
the reversal potential of the HCO3
−-activated currents, sug-
gesting that Cl− does not affect NBCe1-B stoichiometry. Finally,
similar experiments with NBCe1-A showed that rising Cl−in up
to 140 mM actually increased the activity of NBCe1-A by
∼20% (Fig. 1 C–E).
To determine the specificity of the inhibition, we tested the
effect of extracellular Cl− (Cl−out) and of other intracellular
halides. Fig. S1A shows that removal of Cl−out minimally inhibited
the current, as was observed on the leak current. Correction for
the effect of Cl−out on the leak current shows that Cl
−
out had no
statistical effect on NBCe1-B activity (Fig. S1B). Fig. S2 C and D
show that the effect of Cl−in is highly specific in that raising Cl
−
in
from 5 to 10 mM inhibited NBCe1-B by approximately 40%,
whereas addition of 5 mM intracellular Br−, I−, or NO3
− had
no effect.
Regulation by Cl−in Is Mediated by NBCe1-B GXXXP Motifs. A GXXXP
motif was identified as an essential part of a Cl− interacting site in
the ClC Cl− transporters (32, 33). Mutations within this motif al-
tered Cl− transport and coupling in ClCs (34, 35). Recently, we
reported that regulation of slc26a2 by extracellular Cl− is altered
by mutations in slc26a2 GXXXP motif (36). NBCe1-B has three
GXXXP motifs in the N terminus (Fig. S2), with the first motif in
the autoinhibitory domain (AID) that is present in many NBCs,
but not in NBCe1-A (Fig. S2A). The predicted localization of the
GXXXP motifs in the N terminus of NBCe1-B and their po-
tential contacts are modeled in Fig. S3. Several regulatory fac-
tors, including inhibition by the WNK/SPAK pathway and
activation by the IRBIT/PP1 pathway (22, 24) and by PI(4,5)P2
(24), converge on the AID, and thus we asked whether regula-
tion by Cl−in requires the AID GXXXP motif. Because the high
affinity inhibition by Cl−in is seen only after activation of NBCe1-
B by IRBIT, we determined how mutations of residues in the
AID GXXXP motif (Fig. 2A) affect the activity of NBCe1-B and
regulation by IRBIT. Unexpectedly, Fig. 2B shows that mutating
even a single residue in the GXXXP motif, the His to either
Ala or to the reverse charge Asp, resulted in full activation of
NBCe1-B and no further activation by IRBIT. Fig. 2C shows that
mutation of the His and of the Gly and Pro in the GXXXP motif
had no effect on IRBIT binding, indicating that the IRBIT
binding domain [NBCe1-B-(40-62) (24)] is intact in these mutants.
Rather, it is possible that the mutations caused a conformational
change in the AID that prevented its interaction with another N
terminus domain. Additional mutants were tested for the effect of
Cl−in are NBCe1-B(Δ40-62) and NBCe1-B(Δ1-95). These mutants
were used because they retain full activity (Fig. 2B and refs. 24 and
37), whereas NBCe1-B(Δ1-95) lacks the first GXXXP motif and
NBCe1-B(Δ40-62) lacks IRBIT binding (Fig. 2C).
Fig. 3A shows that all mutations in the 32GXXXP36 motif
shifted the concentration dependence for inhibition by Cl−in to
the right, resulting in an apparent Ki of 29.3 ± 2.6 mM, and that
the inhibition was not affected further by coexpression of
32GP36/AA (and 34H/A) with IRBIT. However, the activity of
the mutants was still strongly inhibited at Cl−in above 20 mM.
This may represent Cl− binding to a site containing one of the
other GXXXP motifs. To test these possibilities, the effect of
mutating the other GXXXP motifs was tested. Mutation of
the third 383GXXXP387 motif of NBCe1-B and of the second
339GXXXP343 motif of NBCe1-A, which are predicted to be at
the boundary between the cytoplasmic N terminus and the trans-
membrane domains (Fig. S3), resulted in retention of the proteins
in the ER, and thus the role of these motifs in inhibition by Cl−in
could not be tested.
Mutating the second 195GXXXP199 motif slightly reduced, but
did not prevent, interaction of NBCe1-B with IRBIT (Fig. 2D).
Nevertheless, the 195GP199/AA mutation resulted in full activa-
tion of the transporter in the absence of IRBIT, as evident from
a lack of further activation by IRBIT (Fig. 3B). The 195GP199/AA
mutation reduced the affinity for inhibition by Cl−in to a similar
degree as the 32GP36/AA mutant. Importantly, NBCe1-B(32GP36/
AA;195GP199/AA) with the first and second GXXXP motifs mu-
tated was no longer inhibited by Cl−in. In addition, IRBIT in-
teraction with the 195GP199/AA mutant also resulted in complete
elimination of the inhibition by Cl−in. The latter would suggest
that binding of IRBIT to NBCe1-B(195GP199/AA) induces a long
range conformational change at the 32GP36 region. To further
probe the role of the two GXXXP motifs we measured the ac-
tivity of NBCe1-B(Δ40-62) and NBCe1-B(Δ1-95) because these
constructs retain full activity (ref. 37 and Fig. 2A) and NBCe1-B
(Δ1-95) is missing the entire AID, including the 32GXXXP36
motif. Fig. 3D shows that the two constructs lost inhibition by low
Cl−in but retained inhibition by high Cl
−
in between 40 and 140 mM.
As expected, mutation of the 195GP199/AA motif in NBCe1-
B(Δ1-95) eliminated inhibition by Cl−in.













The results in Figs. 1–3 suggest that the two NBCe1-B
GXXXP motifs participate in sensing and regulation by Cl−in.
The 32GXXXP36 motif in the AID is cryptic and does not
respond to Cl−in before its exposure by IRBIT. The second
195GXXXP199 motif site mediates inhibition by high Cl−in.
This is concluded from the data showing that NBCe1-B(32GP36/
AA;195GP199/AA) activity in not inhibited by Cl−in and that NBCe1-
B(Δ1-95) has low apparent affinity for Cl−in that is eliminated by
the 195GP199/AA mutation.
A Cryptic Cl−in-Dependent Inhibitory Site in NBCe1-A. NBCe1-B(Δ1-
95) retains inhibition by high Cl−in, and the sequence of NBCe1-
B(96-1079) is identical to NBCe1-A(41-1024); yet NBCe1-A is
resistant to inhibition by Cl−in. This suggests that NBCe1-A(1-
41) may offer protection of NBCe1-A from inhibition by Cl−in
and prompted us to test whether NBCe1-A is also regulated by
a cryptic Cl−in-sensing site. Such regulation might be mediated by
the conserved 150GXXXP154 motif in NBCe1-A (Figs. S2 and
S3). The experiments depicted in Fig. 4 attempted to test this
hypothesis. Because no activator similar to IRBIT is known for
NBCe1-A, we took the approach of systematic deletion of
portions of NBCe1-A N terminus and tested for inhibition by
140 mM Cl−in. Previous studies reported that deletion of NBCe1-A
(1-43) resulted in 50–70% inhibition of NBCe1-A activity when
expressed in Xenopus oocytes, even in the presence of only
2 mM Cl− (38). Therefore, in preliminary experiments we
compared the activity of wild-type NBCe1-A and the trunca-
tion mutants examined in Fig. 4 in the presence of 5 mM Cl−in.
Interestingly, the truncation had no effect on NBCe1-A activity
when expressed in HeLa cells. This is shown for Δ13-NBCe1-A
with deletion of residues 29–42. The reason for the different
findings is not known at present, although it is possible that NBCs
may behave differently in Xenopus oocytes and mammalian cells.
Fig. 2. Effect of NBCe1-B GXXXP motifs, NBCe1-B(Δ1-95), NBCe1-B(Δ40-62), and NBCe1-B(195GP199/AA) on NBCe1-B activity and interaction with IRBIT. (A)
N-terminal sequence of NBCe1-B with the G, P, and H in the GXXXP motif that were mutated to A. (B) Summary of the current density in pA/pF of the
indicated NBCe1-B mutants and in the presence and absence of IRBIT, as indicated. The last column shows the activity of NBCe1-A for comparison. The
numbers in the columns are the number of experiments in each condition. Note that all NBCe1-B mutations eliminated activation of NBCe1-B by IRBIT. (C)
Effect of the indicated NBCe1-B mutants on NBCe1-B surface expression and its interaction with IRBIT. Note that although the GXXXP motif mutations
eliminated activation by IRBIT, they had no effect on IRBIT binding to NBCe1-B or NBCe1-B surface expression. (D) Mutation of the second NBCe1-B GXXXP
motif (195GP199/AA) only slightly reduced interaction of NBCe1-B with IRBIT. The experiments in C and D are representative of three similar experiments.
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The effect of the various NBCe1-A N-terminal truncations on
inhibition by Cl−in is presented in Fig. 4A, which shows that
deletion of the first 48 residues induced a ∼35% inhibition of
NBCe1-A activity by 140 mM Cl−in. The NBCe1-A sequence
required to observe the full inhibition by Cl−in was determined by
the deletions depicted in Fig. 4A. Most deletions had no effect,
but deletion of the 13 residues 29–42 to obtain Δ13-NBCe1-A
resulted in the inhibition of NBCe1-A by Cl−in in the concen-
tration range of 20–140 mM (Fig. 4B). Finally, the 150GP154/AA
mutation in Δ13-NBCe1-A eliminated the inhibition by Cl−in
(Fig. 4B). These findings indicate that NBCe1-A has a cryptic
Cl−in interacting site. The data provide further evidence for the
role this GXXXP motif in the inhibition by Cl−in.
The GXXXP Motif-Containing Site Mediates Regulation of NBCe2-C by
Cl−in. Fig. S2A shows that the first GXXXP motif is present in
most NBCs. To determine whether the first GXXXP motif is
required for regulation by Cl−in in other NBCs, we evaluated its
role in NBCe2-C, which was selected because it is an electro-
genic Na+-HCO3
− cotransporter (39, 40), and thus the current
mediated by NBCe2-C can be recorded while altering Cl−in in
the patch pipette. First, we determined the effect of IRBIT on
NBCe2-C. Fig. 5A shows that the positively charged arginine
cluster required for regulation of the NBCs by IRBIT and
PI(4,5)P2 (24) (highlighted in red) is absent in NBCe2-C. The
lack of activation of NBCe2-C by IRBIT is shown in Fig. 5B,
further supporting the involvement of the arginine cluster in the
regulation of other NBCs by IRBIT.
Fig. 5C shows examples of current density and the I/V curves
mediated by NBCe2-C in the presence of 5 and 140 mM Cl−in.
Cl−in strongly inhibited NBCe2-C activity, again without chang-
ing the reversal potential, and thus the stoichiometry of the
transport process. The plot in Fig. 5E shows that Cl−in inhibited
NBCe2-C by approximately 72%, with an apparent Km of
approximately 22.6 ± 3.2 mM. Notably, Fig. 5D (representative
traces) and Fig. 5E show that the 34GP38/AA mutation virtually
eliminated the inhibition by up to 140 mM Cl−in. Hence, it seems
that the GXXXP motif is required for regulation of NBC
transporters by Cl−in, which may be a property of other SLC4
family members possessing the GXXXP motif.
Discussion
Cl− is a major cellular anion and participates in numerous cel-
lular functions that contribute to ion and fluid homeostasis. Cl−in
varies between 5 and 60 mM, depending on the cell type, and is
determined by the activity of several ion/substrate transporters
and ion channels. For example, in different neurons Cl−in is
between 5 and 30 mM (41, 42), whereas in epithelia it is between
10 and 60 mM (19, 43, 44). Furthermore, Cl−in is not constant
and can vary widely in specific cell types. Specifically, in secretory
ducts the resting Cl−in is ∼35 mM and decreases to 4 mM toward
the latter phase of Cl− absorption and HCO3
− secretion (7, 19).
The significance of changes in Cl−in has historically focused on
the effect on plasma membrane Cl− gradients and transepithelial
Cl− transport. The present study has uncovered a previously
unidentified function of Cl−in as a signaling ion that regulates the
activity of other transporters, including transporters that do not
Fig. 3. Mutations of NBCe1-B GXXXP motifs alter inhibition by Cl−in. (A) Effect of the indicated first GXXXP motif mutants on inhibition of NBCe1-B by Cl
−
in.
The results of NBCe1-B+IRBIT are reproduced from Fig. 1E. The numbers next to the symbols indicate the number of experiments with the corresponding
currents. Note that although IRBIT binds to NBCe1-B(32GP38/AA), it had no further effect on the inhibition by Cl−in. *P < 0.01 relative to NBCe1-B+IRBIT for all
conditions, except for 140 mM, where it is only for the NBCe1-B(34H/A) mutant. (B) Effect of the NBCe1-B(195GP199/AA) mutant alone and of the double
mutant NBCe1-B(32GP38/AA;195GP199/AA) on inhibition of NBCe1-B by Cl−in. The results of NBCe1-B are reproduced from Fig. 1D. The numbers next to the
symbols indicate the number of experiments with the corresponding currents. Note that NBCe1-B(32GP38/AA;195GP199/AA) is not inhibited by Cl−in and that
IRBIT eliminated inhibition of NBCe1-B(195GP199/AA) by Cl−in. *P < 0.01 relative to NBCe1-B;
#P < 0.001 relative to NBCe1-B(195GP199/AA). (C) Example traces
and (D) mean ± SEM of the current recorded with the indicated NBCe1-B mutants. Note that the 195GP199/AA mutation eliminated the residual low affinity
inhibition of NBCe1-B(Δ1-95) by Cl−in. *P < 0.05 or better relative to NBCe1-B(Δ1-95).













transport Cl−, such as the NBCs. The regulation seems to be
mediated by sites containing GXXXP motifs, which have been
associated with Cl− sensing and transport in other transporters
(32–36). In the ClC channels, residues in the GXXXP motifs from
several regions are brought together to form the Cl− binding sites
(32). Altogether seven residues are involved in Cl− binding. The
conducting pore E148 is found in a GXXXP motif but does not
participate in Cl− binding. The other six residues that form polar
and hydrophobic interactions generate an electrostatically fa-
vorable environment for anion binding (32). Hence, the envi-
ronment generated by interactions of the GXXXP motif form
the pocket in which several residues coordinate Cl− binding.
Indeed, translocation of the first NBCe1-B GXXXP motif
GVHVP to another position in the N terminus or to the end of
the C terminus failed to restore inhibition by Cl−in. Contribution
of residues to the GXXXP motifs to form the Cl− pocket makes
it virtually impossible to predict the residues that cooperate with
the NBCs GXXXP motifs to form the Cl− binding sites without
the actual structure. Nevertheless, potential interactions that the
two GXXXP motifs in the NBCe1-B model form to coordinate
Cl− binding are shown in Fig. S3. The significance of these po-
tential interactions awaits availability of the NBCe1-B structure.
Regulation by Cl−in differs in complexity depending on the
NBC transporter involved. Regulation of NBCe2-C seems to be
mediated mostly by the exposed first GXXXP motif. Inhibition
by Cl−in did not require exposure of a cryptic site, and mutation
of the first NBCe2-C GXXXP motif nearly eliminated inhibition
by Cl−in. The simple regulation of NBCe2-C may reflect the lack
of activation of this transporter by IRBIT and the need to expose
the GXXXP motif. In addition the apparent affinity of NBCe2-C
for inhibition by Cl−in was lower than that for NBCe1-B. A more
complex regulation was observed with NBCe1-A. In the basal
state NBCe1-A is resistant to inhibition by physiological levels of





sensing NBCe1-A GXXXP motif seems to be a cryptic site, and
deletion of part of the N terminus was required to observe the
inhibition by Cl−in. This raises the possibility that the N terminus
of NBCe1-A functions as a regulatory domain, similar to the N
terminus of NBCe1-B, interacting with an unknown cellular
factor(s). The cellular mechanism(s) that modulates the function
of the NBCe1-A N terminus remains to be identified.
Regulation of NBCe1-B transport function by Cl−in is quite
complex. Inhibition by the high affinity Cl−in site 1 is cryptic and
is not observed until NBCe1-B is activated by IRBIT (Fig. 1),
which prevents its autoinhibition (21, 23). Mutations in the first
GXXXP motif prevented inhibition by Cl−in between 5 and 20 mM,
whereas mutation of the second GXXXP motif in the IRBIT-
activated conformation (Fig. 3B), combined mutations of the
first and second GXXXP motifs, or deletion of the first GXXXP
motif in combination with mutation of the second GXXXP motif
was required to eliminate inhibition by a higher Cl−in (Fig. 3D).
These findings suggest that NBCe1-B can sense a broad range of
changes in Cl−in. In the resting state Cl
−
in can be as high as
60 mM (45). Under these conditions the unactivated NBCe1-B
operates at approximately 40% of maximal activity, and re-
duction in Cl−in only gradually and modestly increases its activity.
When the cells are stimulated with any IP3-generating receptor,
IRBIT is released from the IP3 receptors (25, 27) and activates
NBCe1-B (27). This likely happens while Cl−in is still high and
the activity of NBCe1-B remains unchanged. Accordingly, we
predict that only when Cl−in is reduced to below 20 mM the
activity of NBCe1-B starts to increase and continues to do so as
Cl−in continues to decline.
The complex regulation of IRBIT-activated NBCe1-B by Cl−in
can potentially have several functional roles. A dramatic increase
in NBCe1-B transport when Cl−in is reduced would be predicted
to activate the Na+/K+ pump (via Na+ influx) and cellular Cl−/
HCO3
− exchangers (via HCO3
− influx), thereby dampening
NBCe1-B transport, increasing Cl−in and decreasing cellular
ATP utilization. Hence, changes in Cl−in can serve to adjust
metabolic activity. A second advantage for this mode of regula-
tion is that the activities of NBCe1-B and the Cl−/HCO3
−
exchangers would become reciprocally coupled in a feedback
mechanism through Cl−in. For example, an increase in Cl
−/
HCO3
− exchanger activity would increase Cl−in resulting in the
inhibition of NBCe1-B activity. Inhibition of NBCe1-B activity
would reduce intracellular HCO3
−, leading to a decrease in Cl−/
HCO3
− exchanger activity and a decrease in Cl−in that would
then stimulate NBCe1-B activity.
The regulation of NBCe1-B by Cl−in should have profound
role in Cl− absorbing and HCO3
− secreting CFTR-expressing
epithelia, found in the salivary and pancreatic ducts, the in-
testine, and the lung (7). As ductal Cl− absorption and HCO3
−
secretion progresses, ductal Cl−in is reduced from approximately
30 to 4–5 mM (7). In the proximal portion of the duct most Cl−
exits the cells through CFTR to support HCO3
− secretion, and in
the terminal portion of the duct CFTR sets Cl− at the low
concentration of 4–5 mM as modeled in refs. 46 and 47. In
Fig. 4. A cryptic GXXXP motif mediates inhibition of NBCe1-A by Cl−in. (A)
Comparison of the activity of NBCe1-A in the presence of 5 (dotted columns)
or 140 (stripped columns) mM Cl−in of the indicated truncations in the N
terminus, shown under the columns. The results are given as mean ± SEM of
the number of experiments indicated in the columns. *P < 0.01, #P < 0.05
relative to 140 mM Cl−in of the same mutant. (B) Effect of Cl
−
in on the activity
of Δ13-NBCe1-A (black) and Δ13-NBCe1-A(150GP154/AA) (red). Results are
given as mean ± SEM of the number of experiments indicated next to the
symbols. *P < 0.01 relative to Δ13-NBCe1-A.
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salivary and pancreatic ducts (and likely other epithelia), fluid
and electrolyte secretion is synergistically activated by Ca2+ and
cAMP signaling pathways (27, 48, 49) that is mediated by IRBIT
(27). As Cl− is absorbed and HCO3
− is secreted across the apical
membrane by the combined actions of CFTR and SLC26a6, the
luminal HCO3
− concentration is elevated and the HCO3
− gra-
dient across the luminal membrane is increased. To continue
transcellular HCO3
− secretion, basolateral NBCe1-B–mediated
HCO3
− influx increases, reducing the cell-to-lumen HCO3
−
gradient and favoring continued HCO3
− secretion. The coupling
of basolateral NBCe1-B transport and apical Cl−/HCO3
− ex-
change becomes particularly crucial in the distal port of the duct
where the luminal Cl− concentration is low and the luminal
HCO3
− concentration is very high. To increase luminal HCO3
−
from approximately 120 to 140 mM requires massive HCO3
− influx.
Reduction of ductal Cl−in to 4–5 mM (19), coupled with IRBIT
interaction with NBCe1-B, profoundly activates NBCe1-B to in-
crease HCO3
− influx and support high rate of HCO3
− secretion.
In the present studies we focused on the modulation of NBCs
by Cl−in. Sequence analysis of several additional transporters,
including the Cl− transporters, CFTR, NKCC1, NKCC2,
KCC, NCC, and many SLC26 transporters, revealed that they
possess at least one GXXXP motif predicted to be in a cyto-
plasmic domain. It will be of particular interest to determine
whether the GXXXP motif(s) functions as a Cl−in sensor in
other transporters.
Methods
Plasmid Construction and Solutions. The p3xFLAG-CMV-7.1/IRBIT, pEGFP-C1/
NBCe1-B, pCDNA 3.1+/NBCe1-A, and pEGFP-C1/NBCe2-C constructs were
described previously (23, 24, 40). The GXXXP motif mutants and deletions in
NBCe1-B and NBCe1-A were generated by PCR. All constructs were verified
by sequencing of the entire ORFs. In most experiments the bath solution
contained 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 10 mM Hepes
(pH 7.4 with NaOH), and 10 mM glucose. Na+-free solutions were prepared
by replacing Na+ with N-methyl-D-glucamine (NMDG) and Cl−-free solutions
were prepared by replacing Cl− with gluconate. HCO3
–-buffered solutions
were prepared by replacing 25 mM Na+ anion with 25 mM Na+-HCO3
– and
reducing Hepes to 2.5 mM. HCO3
–-buffered solutions were gassed with 5%
CO2 and 95% O2. The osmolarity of all solutions was adjusted to 310 mOsmol
with the major salt.
Fig. 5. A GXXXP motif-dependent regulation of NBCe2-C by Cl−in. (A) Position of the GXXXP motif (blue) in NBCe1-B and NBCe2-C, and lack of the arginines
in NBCe2-C mediating regulation of NBCe1-B by IRBIT (red). (B) Lack of activation of NBCe2-C by IRBIT. (C and D) Example traces of the currents time course in
pA/pF (circles) and example I/V plots for NBCe2-C (C) and NBCe2-C(34GP38/AA) (D) at 10 (black) and 140 mM Cl−in (red). (E) Effect of Cl
−
in on the activity of
NBCe2-C and NBCe2-C(34GP38/AA). The results are plotted as mean ± SEM of the number of experiments shown next to the symbols. #P < 0.05, *P < 0.01
relative to NBCe2-C.













Surface Expression and Coimmunoprecipitation. Surface expression was assayed
by biotinylation of surface proteins. Cells were incubated with 0.5 mg/mL
EZ-LINK Sulfo-NHS-LC-biotin (Thermo Scientific) for 30 min at 0 °C. The cells
were then treated with 100 mM glycine for 10 min to terminate the
biotinylation reaction, washed with PBS, and lysed with titon-based lysis buffer
described previously (24). Biotinylated proteins were captured with avidin
beads by incubation for 2 h at room temperature, and the precipitated
proteins were analyzed by SDS/PAGE.
Coimmunoprecipitation was by incubation of extracted proteins with anti-
Flag (IRBIT) and anti-α-actin (Sigma-Aldrich), and anti-GFP (NBCe1-B and
NBCe2-C) (Invitrogen), antibodies with G Sepharose beads for 2 h at 0 °C.
Beads were collected by brief centrifugation, washed three times with lysis
buffer, and proteins were subjected to SDS/PAGE and the blots probed for
the indicated proteins.
Current Measurement in HeLa Cells. The effect of Cl−in on current mediated by
NBCe1-B, NBCe1-A, and NBCe2-C activity was analyzed in transiently trans-
fected HeLa cells using whole-cell current recording at room temperature,
exactly as detailed previously (24), except for varying pipette solution Cl−
between 5 and 140 mM. Patch clamp pipettes had a resistance of 5–7 MΩ
when filled with KCl-based pipette solution, which allow equilibration of
cytoplasmic and pipette ion composition within 20–30 s of establishing the
whole-cell configuration. The cell capacitance was between 15 and 35 pF.
The pipette solutions contained (in mM): 2 MgSO4, 1 ATP, 0.5 EGTA, and 10
Hepes (adjusted to pH 7.3 with CsOH) and a mixture of CsCl and Cs-gluco-
nate to yield Cl− concentrations of 5, 10, 20, 30, 40, and 140 mM. pH was
adjusted to 7.3 with CsOH. In some experiments the pipette solution con-
tained 5 mM CsCl, 5 mM NMDG-NO3
−, NMDG-Br−, or NMDG-l− and 135 mM
Cs-gluconate. The Hepes-buffered bath solution contained (in mM): 140
NaCl, 5 KCl, 1 MgCl2, 1 CaCl2, 10 glucose, and 10 Hepes (pH 7.4 with NaOH),
and the HCO3
−-buffered solution was prepared by replacing 25 mM NaCl
with equimolar amount of NaHCO3, and the solution was equilibrated with
5% CO2/95% O2. Cl
−-free solutions were prepared by replacing Cl− with
gluconate. The current was recorded by 400-ms rapid alteration of mem-
brane potential (RAMPs) from −60 to +60 mV every 2 s from a holding
potential of 0 mV. Before current recording the junction potential at each
pipetted solution Cl− concentration was offset to 0 using the Axopatch 200B
amplifier. The current recorded at +60 mV was used to calculate current
density as pA/pF. Axopatch 200B patch-clamp amplifier, Digidata -1440A,
and pClamp 10 software (Molecular Devices) were used for data acquisition
and analysis. The currents were filtered at 1 kHz and sampled at 10 kHz.
Statistics. Results are given as mean ± SEM, and significance was analyzed by
Student t test or by ANOVA.
Structure Prediction and Protein Modeling. A segment of mouse NBCe1-B,
consisting of 1,000 amino acids (National Center for Biotechnology Infor-
mation reference sequence NP_061230.2), was submitted to both ROBETTA
(50) and HHPred servers (Max Planck Institute of Developmental Biology). In
general, both servers provided roughly similar homology templates. We
selected one of five coordinates generated by ROBETTA in which the AID
was linked to the homologous domain with a hinge that might allow ro-
tation during activation by IRBIT. One domain spanning residues 1–100 was
identified to be homologous to the Yeast Mitochondrial Processing Pepti-
dase (Protein Data Bank ID 1hr6), another region encompassing residues
101–430 is homologous to human erythrocyte band 3 cytoplasmic domain
(Protein Data Bank ID 1HYN) as we previously reported (24). The trans-
membrane segment spanning residues 431–1000 was identified to be ho-
mologous to the crystal structure of the Uracil Transporter UraA (Protein
Data Bank ID 3qe7). The coordinates provided by the ROBETTA server were
used to generate the final model with PyMOL software.
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